Optimum Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-138
Closed -$24K 955
2020
Q1
$24K Sell
138
-1,387
-91% -$261K 0.01% 549
2019
Q4
$292K Buy
1,525
+800
+110% +$144K 0.09% 218
2019
Q3
$122K Buy
725
+500
+222% +$81.5K 0.04% 341
2019
Q2
$38K Sell
225
-40
-15% -$5.54K 0.01% 561
2019
Q1
$39K Sell
265
-425
-62% -$61.6K 0.01% 562
2018
Q4
$92K Sell
690
-470
-41% -$77K 0.03% 368
2018
Q3
$221K Sell
1,160
-360
-24% -$66.1K 0.06% 290
2018
Q2
$253K Sell
1,520
-140
-8% -$22.5K 0.07% 265
2018
Q1
$279K Sell
1,660
-830
-33% -$139K 0.08% 238
2017
Q4
$407K Sell
2,490
-2,365
-49% -$424K 0.13% 189
2017
Q3
$995K Sell
4,855
-500
-9% -$116K 0.33% 85
2017
Q2
$1.3M Sell
5,355
-1,225
-19% -$288K 0.45% 60
2017
Q1
$1.57M Buy
6,580
+150
+2% +$34.9K 0.56% 47
2016
Q4
$1.35M Sell
6,430
-713
-10% -$148K 0.51% 52
2016
Q3
$1.65M Buy
7,143
+823
+13% +$201K 0.62% 42
2016
Q2
$1.46M Buy
+6,320
New +$1.46M 0.57% 45
2015
Q1
$298K Buy
+1,000
New +$285K 0.09% 219

Other funds holding AGN

Optimum Investment Advisors's AGN Position: Q2 2020 in Review

Optimum Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 138 shares — an estimated $24K sold.

Optimum Investment Advisors first reported a position in AGN in Q1 2015 and held it in 17 quarters. The position peaked at $1.65M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Optimum Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 138 Allergan plc shares in Q2 2020, an estimated $24K.
  • Optimum Investment Advisors first reported a position in Allergan plc in Q1 2015 and held it in 17 quarters.
  • Optimum Investment Advisors's Allergan plc position peaked at $1.65M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Optimum Investment Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.